Stocktoria
Stereotaxis, Inc. STXS
NYSE American · XASE · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2004-08-12
Stereotaxis, Inc. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.4M | $26.9M | $26.8M | $28.1M | $35.0M | $26.6M | $28.9M | $29.3M | $31.1M | $32.2M |
| Gross profit | $17.1M | $14.6M | $14.9M | $18.5M | $23.2M | $19.0M | $22.8M | $23.6M | $20.4M | $24.6M |
| R&D expense | $9.4M | $9.8M | $10.3M | $10.6M | $10.2M | $8.1M | $9.0M | $8.2M | $6.7M | $5.5M |
| Operating income | -$22.1M | -$24.7M | -$21.8M | -$18.8M | -$12.9M | -$6.7M | -$4.8M | -$2.5M | -$5.9M | -$6.4M |
| Interest expense | — | — | — | — | — | — | — | $16,566 | $179,844 | $2.5M |
| Net income | -$21.6M | -$24.0M | -$20.7M | -$18.3M | -$10.7M | -$6.6M | -$4.6M | $116,756 | -$5.9M | -$5.3M |
| EPS (diluted) | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 | $-0.11 | $-0.10 | $-0.03 | $-0.32 | $-0.54 |
| Operating cash flow | -$13.7M | -$8.5M | -$9.1M | -$8.4M | -$2.9M | -$3.5M | -$4.6M | -$2.5M | -$4.7M | -$6.6M |
| Cash & equivalents | $13.4M | $12.2M | $19.8M | $8.6M | $38.7M | $43.9M | $30.2M | $10.8M | $3.7M | $8.5M |
| Inventory | $9.6M | $8.3M | $8.4M | $7.9M | $4.4M | $3.3M | $1.8M | $1.2M | $1.1M | $5.4M |
| Total assets | $52.3M | $46.7M | $41.9M | $53.4M | $61.0M | $55.5M | $43.6M | $18.5M | $10.7M | $21.0M |
| Total liabilities | $33.5M | $35.3M | $20.0M | $21.5M | $21.6M | $15.2M | $15.1M | $11.2M | $31.3M | $36.5M |
| Shareholders' equity | $13.5M | $6.1M | $16.3M | $26.3M | $33.8M | $34.6M | $22.8M | $1.3M | -$26.6M | -$21.5M |
Growth · year-over-year · Revenue CAGR 0.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +20.3% | +0.5% | -4.9% | -19.6% | +31.5% | -7.9% | -1.5% | -5.8% | -3.2% | -14.6% |
| Net income growth | — | — | — | — | — | — | -4032.4% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001289340 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.